Literature DB >> 29283981

COLORADO AGE-RELATED MACULAR DEGENERATION REGISTRY: Design and Clinical Risk Factors of the Cohort.

Anne M Lynch1, Jennifer L Patnaik1, Jennifer N Cathcart1, Marc T Mathias1, Frank S Siringo1, E Lacey Echalier1, Brandie D Wagner2, Scott C N Oliver1, Paula E Pecen1, Jeffrey L Olson1, Stuart L Fine1, Alan G Palestine1, Naresh Mandava1.   

Abstract

PURPOSE: To study new and existing risk factors related to age-related macular degeneration (AMD) phenotypes in a Colorado cohort.
METHODS: Age-related macular degeneration was categorized into early, intermediate, or advanced forms. Controls (n = 180) were patients with cataract and no AMD. Demographic and clinical data were gathered by patient interview and verified by chart review. Image data were reviewed by vitreoretinal specialists. Statistical analysis included univariable and multivariate logistic regression analysis (P < 0.05).
RESULTS: Among the 456 patients with AMD, 157 (34.4%), 80 (17.6%), and 219 (48.0%) had the early/intermediate, geographic atrophy, and neovascular forms of the disease, respectively. Adjusted for age, African-American race was associated with a reduced risk of early/intermediate (adjusted odds ratio [AOR] = 0.08, confidence interval [CI] = 0.01-0.67) and neovascular AMD (AOR = 0.15, CI = 0.03-0.72). A family history of AMD was a risk factor for early/intermediate (AOR = 4.08, CI = 2.30-7.25), geographic atrophy (AOR = 8.62, CI = 3.77-19.7), and neovascular AMD (AOR = 3.76, CI = 2.16-6.56). A history of asthma was related to the early/intermediate form of AMD (AOR = 2.34, CI = 1.22-4.46).
CONCLUSION: Studying AMD in specific populations may reveal novel risk factors such as our finding of a relationship between asthma history and AMD.

Entities:  

Mesh:

Year:  2019        PMID: 29283981     DOI: 10.1097/IAE.0000000000002023

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  9 in total

1.  An Exploratory Study to Investigate the Utility of Clinical Screening for Neurodegenerative Disease in Age-Related Eye Disease Research.

Authors:  Victoria S Pelak; Yosbelkys Martin Paez; Jennifer L Patnaik; Samantha K Holden; Prem S Subramanian; Marc T Mathias; Naresh Mandava; Anne M Lynch
Journal:  J Neuroophthalmol       Date:  2022-04-27       Impact factor: 4.415

2.  Sex and Age-Related Differences in Complement Factors Among Patients With Intermediate Age-Related Macular Degeneration.

Authors:  A Itzam Marin; Felix Poppelaars; Brandie D Wagner; Alan G Palestine; Jennifer L Patnaik; V Michael Holers; Ashley A Frazer-Abel; Marc T Mathias; Niranjan Manoharan; Cheryl N Fonteh; Naresh Mandava; Anne M Lynch
Journal:  Transl Vis Sci Technol       Date:  2022-05-02       Impact factor: 3.048

3.  Association of Systemic Inflammatory Factors with Progression to Advanced Age-related Macular Degeneration.

Authors:  Brandie D Wagner; Jennifer L Patnaik; Alan G Palestine; Ashley A Frazer-Abel; Rebecca Baldermann; V Michael Holers; Marc T Mathias; Naresh Mandava; Anne M Lynch
Journal:  Ophthalmic Epidemiol       Date:  2021-04-08

4.  Complement factors and reticular pseudodrusen in intermediate age-related macular degeneration staged by multimodal imaging.

Authors:  Anne M Lynch; Alan G Palestine; Brandie D Wagner; Jennifer L Patnaik; Ashley A Frazier-Abel; Marc T Mathias; Frank S Siringo; Vernon Michael Holers; Naresh Mandava
Journal:  BMJ Open Ophthalmol       Date:  2020-01-14

5.  Proteomic Profiles in Advanced Age-Related Macular Degeneration Using an Aptamer-Based Proteomic Technology.

Authors:  Anne M Lynch; Brandie D Wagner; Sophie J Weiss; Kirsten M Wall; Alan G Palestine; Marc T Mathias; Frank S Siringo; Jennifer N Cathcart; Jennifer L Patnaik; Daniel W Drolet; Nebojsa Janjic; Naresh Mandava
Journal:  Transl Vis Sci Technol       Date:  2019-01-25       Impact factor: 3.283

6.  Sex Differences in RANTES (CCL5) in Patients With Intermediate Age-Related Macular Degeneration (AMD) and Controls With no AMD.

Authors:  Cheryl N Fonteh; Alan G Palestine; Brandie D Wagner; Jennifer L Patnaik; Marc T Mathias; Naresh Mandava; Rebecca Baldermann; Anne M Lynch
Journal:  Transl Vis Sci Technol       Date:  2022-02-01       Impact factor: 3.283

7.  Increased Systemic C-Reactive Protein Is Associated With Choroidal Thinning in Intermediate Age-Related Macular Degeneration.

Authors:  Rachel C Chen; Alan G Palestine; Anne M Lynch; Jennifer L Patnaik; Brandie D Wagner; Marc T Mathias; Naresh Mandava
Journal:  Transl Vis Sci Technol       Date:  2021-10-04       Impact factor: 3.283

8.  Mental health and visual acuity in patients with age-related macular degeneration.

Authors:  Cheryl N Fonteh; Marc T Mathias; Naresh Mandava; Niranjan Manoharan; Anne M Lynch; Roxanne Navo; Jennifer L Patnaik
Journal:  BMC Ophthalmol       Date:  2022-10-02       Impact factor: 2.086

9.  Plasma Biomarkers of Reticular Pseudodrusen and the Risk of Progression to Advanced Age-Related Macular Degeneration.

Authors:  Anne M Lynch; Brandie D Wagner; Alan G Palestine; Nebojsa Janjic; Jennifer L Patnaik; Marc T Mathias; Frank S Siringo; Naresh Mandava
Journal:  Transl Vis Sci Technol       Date:  2020-09-11       Impact factor: 3.283

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.